Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Unlike erythropoietin, which primarily stimulates red blood cell production, ARA290 provides tissue protection and neuroprotective benefits
Common Contraindications Active or recent cancer (BPC-157 and TB-500 angiogenesis concern), Wilson's disease or other copper metabolism disorders (GHK-Cu component), pregnancy or breastfeeding (no safety data for any component), and competitive sport at WADA-tested levels (BPC-157 and TB-500 are listed under WADA category S0 Unapproved Substances) are commonly cited reasons not to research KLOW
Proper brain functioning requires adequate folic acid levels
These injections are administered into the muscle, allowing them to bypass the digestive system for faster absorption and improved bioavailability
The subcutaneous route produces more consistent bioavailability based on animal pharmacokinetic data
US$ 21.38
US$ 24.58
US$ 24.60
